1-6 of 6
Michael Roderick Cook
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2 nd Line CAR T Therapy

Michael Schneider, Elise A. Chong, Stefan K. Barta, Sunita D. Nasta, Jakub Svoboda, Jordan Carter, Michael Roderick Cook, Nasheed Hossain, Stephen J. Schuster, Heather Difilippo, John P Plastaras, Michael Lariviere, Marco Ruella, David L. Porter, Noelle Frey, Daniel J. Landsburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 5123.
https://doi.org/10.1182/blood-2024-202736
Published: 2024
Journal Articles

Comparison of CRS- and Icans-Related Outcomes for Large B Cell Lymphoma Patients Treated with Commercial Axicabtagene Ciloleucel with or without Prophylactic Dexamethasone

Alison Carulli, Hayden Elliott, Brendan Mangan, James Whittenburg, Elise A. Chong, Sunita D. Nasta, Jakub Svoboda, Stefan K. Barta, David L. Porter, Jordan S. Carter, Michael Roderick Cook, Nasheed Hossain, Saar Gill, Alfred L. Garfall, Christopher Catania, Colleen R. Kucharczuk, Stephen J. Schuster, Noelle Frey, Daniel J. Landsburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 2275.
https://doi.org/10.1182/blood-2024-203726
Published: 2024
Journal Articles

Real-World Evidence in the United States (US) of the Impact of Bridging Therapy Prior to Axicabtagene Ciloleucel (Axi-Cel) for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)

Michael Roderick Cook, Roni Shouval, Miguel-Angel Perales, Evandro Bezerra, Alex Niu, Saurabh Dahiya, Loretta J. Nastoupil, Caron A. Jacobson, L. Elizabeth Budde, Amanda L. Olson, Brent R. Logan, Zhen-Huan Hu, Hai-Lin Wang, Zhong-Cheng Luo, Jenny J. Kim, Harry W. Smith, Andrew Lee, Fang Sun, Marcelo Pasquini, Frederick L. Locke
Journal: Blood
Blood (2023) 142 (Supplement 1): 103.
https://doi.org/10.1182/blood-2023-175034
Published: 2023
Journal Articles

Improved Survival Outcomes for Intensive Versus Standard Chemoimmunotherapy in Primary Mediastinal B-Cell Lymphoma: A Meta-Analysis of 4068 Patients

Michael Roderick Cook, Lacey S. Williams, Scott C Dorris, Paul Kolm, Kieron Dunleavy
Journal: Blood
Blood (2022) 140 (Supplement 1): 9567–9568.
https://doi.org/10.1182/blood-2022-162852
Published: 2022
Journal Articles

P53 Overexpression Predicts Poor Outcome in High-Grade B-Cell Lymphoma - a Comparative Analysis of Aggressive B-Cell Lymphomas

Michael Roderick Cook, Sumeyye Culfaci, Mihriye Mete, Metin Ozdemirli, Kieron Dunleavy
Journal: Blood
Blood (2022) 140 (Supplement 1): 12096–12097.
https://doi.org/10.1182/blood-2022-162785
Published: 2022
Journal Articles

Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19

Michael Roderick Cook, MD, Kaitlyn C Dykes, MDBS, Katherine White, Jaeil Ahn, PhD, Nathan Cobb, MD, Catherine Lai, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-138941
Published: 2020